Breaking News
2 hours ago
Vaibhavi M.
Artelo expands ART27.13 into GLP-1 therapy market for muscle preservation, supported by CAReS trial data and a new patent targeting muscle loss in metabolic and obesity treatments.
Vaibhavi M.
Oragenics reports going concern warning in FY2025 audit, disclosed under NYSE rules, highlighting financial risk while confirming no changes to previously filed financial statements.
Vaibhavi M.
Thermo Fisher partners with SHL Medical to expand Ridgefield site, integrating Molly autoinjector assembly with sterile fill-finish manufacturing for drug-device products in chronic diseases.
Vaibhavi M.
Recursion appoints Vicki Goodman as Chief Medical Officer to lead clinical strategy, strengthen oncology development capabilities, and support pipeline advancement and upcoming regulatory milestones.
Vaibhavi M.